• Entity registrant name: Concordia International Corp. (CIK: 0001642271)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1642271/000164227118000008/0001642271-18-000008-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1642271/000164227118000008/cxrx-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • XBRL Cloud Rendering (requires license): Click to open XBRL Cloud Component Rendering
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001642271
  • Open this page in separate window: Click

    • * * *

    Component: (Network and Table)
    Network
    1002000 - Statement - Consolidated Statements of Loss
    (http://concordiarx.com/role/ConsolidatedStatementsOfLoss)
    Table (Implied)
    Slicers (applies to each fact value in each table cell)
    Reporting Entity [Axis] 0001642271 (http://www.sec.gov/CIK)
    Profit or loss [abstract] Period [Axis]
    2017-01-01 - 2017-12-31
    2016-01-01 - 2016-12-31
    2015-01-01 - 2015-12-31
    Profit or loss [abstract]
     
     
     
    Revenue (Note 11)
    626,169,000  
    816,159,000  
    394,224,000  
    Cost of sales (Notes 7 & 25)
    190,632,000  
    221,202,000  
    94,294,000  
    Gross profit
    435,537,000  
     
    594,957,000  
     
    299,930,000  
     
    Operating expenses
     
     
     
    General and administrative
    50,690,000  
    56,455,000  
    29,697,000  
    Selling and marketing
    38,266,000  
    51,133,000  
    23,486,000  
    Research and development
    31,482,000  
    40,637,000  
    14,992,000  
    Acquisition related, restructuring and other
    46,778,000  
    35,968,000  
    57,207,000  
    Share-based compensation (Note 17)
    8,711,000  
    30,753,000  
    16,198,000  
    Initial exchange listing expenses
    0  
    0  
    1,051,000  
    Amortization of intangible assets (Note 8)
    226,425,000  
    182,819,000  
    75,810,000  
    Impairments (Notes 8 & 9)
    1,194,765,000  
    1,132,243,000  
    0  
    Depreciation expense
    1,962,000  
    1,939,000  
    477,000  
    Fair value (gain) loss
    1,406,000  
    (8,929,000) 
    561,000  
    Litigation settlements (Note 19)
    0  
    14,246,000  
    0  
    Total operating expenses
    1,600,485,000  
     
    1,537,264,000  
     
    219,479,000  
     
    Operating income (loss) from continuing operations
    (1,164,948,000) 
     
    (942,307,000) 
     
    80,451,000  
     
    Other income and expense
     
     
     
    Interest and accretion expense (Notes 14)
    506,794,000  
    300,690,000  
    129,195,000  
    Interest income (Note 13)
    (61,302,000) 
    (21,671,000) 
    (311,000) 
    Fair value (gain) loss on derivative financial instruments (Note 13)
    109,580,000  
    2,620,000  
    0  
    Gain on debt settlement (Note 14)
    (21,188,000) 
    0  
    0  
    Foreign exchange (gain) loss
    1,551,000  
    (3,626,000) 
    4,056,000  
    Unrealized foreign exchange (gain) loss (Note 13)
    (72,891,000) 
    128,574,000  
    0  
    Loss from continuing operations before tax
    (1,627,492,000) 
     
    (1,348,894,000) 
     
    (52,489,000) 
     
    Income taxes
     
     
     
    Current income tax expense
    18,491,000  
    36,846,000  
    8,858,000  
    Deferred
    (55,248,000) 
    (71,647,000) 
    (31,922,000) 
    Net loss from continuing operations
    (1,590,735,000) 
     
    (1,314,093,000) 
     
    (29,425,000) 
     
    Net loss from discontinued operations (Note 26)
    0  
    (1,601,000) 
    (2,143,000) 
    Net loss for the year
    (1,590,735,000) 
     
    (1,315,694,000) 
     
    (31,568,000) 
     
    Loss per share, from continuing operations
     
     
     
    Basic loss per share from continuing operations (usd per share)
    (31.10) 
    (25.76) 
    (.81) 
    Diluted loss per share from continuing operations (usd per share)
    (31.10) 
    (25.76) 
    (.81) 
    Loss per share, including discontinuing operations
     
     
     
    Basic loss per share (usd per share)
    (31.10) 
    (25.79) 
    (.87) 
    Diluted loss per share (usd per share)
    (31.10) 
    (25.79) 
    (.87)